|
GOSR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62536650805123E-12 |
| Normal-vs-Stage2 |
4.81000000052134E-07 |
| Normal-vs-Stage3 |
1.67910000004046E-06 |
| Normal-vs-Stage4 |
3.99050000000623E-05 |
| Stage1-vs-Stage2 |
5.285000E-01 |
| Stage1-vs-Stage3 |
2.029000E-01 |
| Stage1-vs-Stage4 |
6.060000E-01 |
| Stage2-vs-Stage3 |
7.020800E-01 |
| Stage2-vs-Stage4 |
9.716600E-01 |
| Stage3-vs-Stage4 |
7.792800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62880819942757E-12 |
| Normal-vs-AfricanAmerican |
1.4931944569696E-11 |
| Normal-vs-Asian |
2.755700E-02 |
| Caucasian-vs-AfricanAmerican |
7.679900E-02 |
| Caucasian-vs-Asian |
2.728600E-01 |
| AfricanAmerican-vs-Asian |
3.382200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.54290002996049E-09 |
| Male-vs-Female |
2.442600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.05349950985101E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
6.69260002972294E-09 |
| Normal-vs-Extreme_Obese |
1.26740000050418E-07 |
| Normal_Weight-vs-Extreme_Weight |
2.704600E-01 |
| Normal_Weight-vs-Obese |
8.151600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.428820E-01 |
| Extreme_Weight-vs-Obese |
2.193600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.992200E-01 |
| Obese-vs-Extreme_Obese |
5.929800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.12330000000294E-05 |
| Normal-vs-Age(41-60Yrs) |
6.27276008913213E-14 |
| Normal-vs-Age(61-80Yrs) |
1.55431223447522E-14 |
| Normal-vs-Age(81-100Yrs) |
3.93579613344741E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.706800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.111400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.462200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.986300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.659300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.305840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.67680322352248E-11 |
| Normal-VS-Type2 PRCC |
1.99160000002863E-06 |
| Normal-VS-KIRP CIMP |
1.54660999999168E-05 |
| Normal-VS-Unclassified PRCC |
3.15449999455097E-08 |
| Type1 PRCC-VS-Type2 PRCC |
6.161700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.751000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.087900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.745600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.075000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.847200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.93169999387999E-09 |
| Normal-vs-N1 |
6.01580000036961E-07 |
| Normal-vs-N2 |
1.804460E-02 |
| N0-vs-N1 |
9.377000E-01 |
| N0-vs-N2 |
7.579600E-01 |
| N1-vs-N2 |
7.541000E-01 |
|
|
